Contributions of BiliaryBea

Contributions by BiliaryBea, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,988 edits includes activity predating the current log.

1. 18:27, 28 Jun 2026 (diff | hist) AmbioPharm 17,173 ±0 m expand §External links
2. 15:22, 19 May 2026 (diff | hist) Amino acid analysis 4,943 ±0 m state the column chemistry and the gradient the figure was obtained on
3. 23:07, 30 Apr 2026 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 ±0 ce per PP:MOS
4. 22:48, 26 Jun 2025 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 +477 expand §Gastrointestinal effects
5. 11:28, 30 Mar 2025 (diff | hist) Patent expiry and biosimilars 3,211 +38 add the effective date to the regulatory table
6. 09:56, 25 Jan 2025 (diff | hist) Dulaglutide 3,990 +123 m add the structural figure and caption it properly
7. 01:01, 16 Jan 2025 (diff | hist) Counterfeit peptide 2,733 +411 add the note that self-submitted reports are a self-selected sample
8. 04:34, 17 Sep 2024 (diff | hist) Weight regain after discontinuation 1,814 ±0 m add the perioperative consideration with the society guidance it comes from
9. 06:20, 17 Aug 2024 (diff | hist) Hypoglycaemia 1,779 ±0 expand §Why glucose dependence matters